RSV Vaccination Associated With Survival Benefit in Heart Failure - EMJ
This story deserves to be shared
Send it to someone who'd care, or post it on your networks.
RSV vaccination was associated with substantially lower all-cause mortality among older adults with heart failure in a multicenter, propensity-matched analysis of U. S. electronic health records.
Researchers identified adults aged 60 years or older with heart failure and compared outcomes according to respiratory syncytial virus vaccination status. After propensity score matching, 777 vaccinated patients and 777 unvaccinated patients had well-balanced baseline demographic characteristics, comorbidities, and medication use.
This article is an excerpt. To read the full content, visit the original source. EMJ
Related articles
A New Injection Makes Fat Cells Self-Destruct, And Might Prevent GLP-1 Weight Regain - ScienceAlert
The new treatment kills off a sub-group of fat cells. (Jian Fan/iStockphoto/Getty Images) Early clinical trials into a new fat reduction treatment have reported promising results, and the treatment takes a more unusual approach: Rather than shrinking fat cells, as most weight loss strategies do, it safely and naturally kills them off. The drug here is CBL-514, which is administered via injection. As well as proving effective at reducing subcutaneous fat (just below the skin), there's evidence it can also reduce visceral fat (stored deeper around the organs). According to the team behind the trials, CBL-514 and its unconventional strategy have the potential to reduce fat in key areas of the body – with further benefits that come with weight loss likely to follow. "We expect that patients will be pleased by the cosmetic effects, such as the flatter stomach that can come with subcutaneous fat loss," says endocrinologist Timothy Garvey, from the University of Alabama at Birmingham, who headed up the trial.
0 comments
No comments yet. Be the first to share your thoughts!